Literature DB >> 29382726

OTUB1 protein suppresses mTOR complex 1 (mTORC1) activity by deubiquitinating the mTORC1 inhibitor DEPTOR.

Linlin Zhao1, Xinbo Wang1, Yue Yu1, Lu Deng2, Lei Chen2, Xiaoping Peng2, Chenchen Jiao2, Guoli Gao3, Xiao Tan2, Weijuan Pan1, Xin Ge4, Ping Wang5.   

Abstract

Mechanistic target of rapamycin (mTOR) complex 1 (mTORC1) integrates various environmental signals to regulate cell growth and metabolism. DEPTOR, also termed DEPDC6, is an endogenous inhibitor of mTORC1 and mTORC2 activities. The abundance of DEPTOR centrally orchestrates the mTOR signaling network. However, the mechanisms by which DEPTOR stability is regulated are still elusive. Here, we report that OTU domain-containing ubiquitin aldehyde-binding protein 1 (OTUB1) specifically deubiquitinates DEPTOR in a deubiquitination assay. We found that OTUB1 directly interacted with DEPTOR via its N-terminal domain, deubiquitinated DEPTOR, and thereby stabilized DEPTOR in a Cys-91-independent but Asp-88-dependent manner, suggesting that OTUB1 targets DEPTOR for deubiquitination via a deubiquitinase activity-independent non-canonical mechanism. The interaction between OTUB1 and DEPTOR was enhanced when the cells were treated with amino acids. Moreover, OTUB1 suppressed amino acid-induced activation of mTORC1 in a DEPTOR-dependent manner and thereby ultimately controlled cellular autophagy, cell proliferation, and size. Our findings reveal a mechanism that stabilizes the mTORC1 inhibitor DEPTOR via OTUB1's deubiquitinase activity. Our insights may inform research into various mTOR activity-related diseases, such as cancer, and may contribute to the identification of new diagnostic markers and therapeutic strategies for cancer treatments.
© 2018 by The American Society for Biochemistry and Molecular Biology, Inc.

Entities:  

Keywords:  DEPTOR; OTU domain-containing ubiquitin aldehyde-binding protein 1 (OTUB1); cancer biology; cell signaling; deubiquitylation (deubiquitination); mTORC1; protein stability; tumor cell biology

Mesh:

Substances:

Year:  2018        PMID: 29382726      PMCID: PMC5880136          DOI: 10.1074/jbc.M117.809533

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  49 in total

1.  Non-canonical inhibition of DNA damage-dependent ubiquitination by OTUB1.

Authors:  Shinichiro Nakada; Ikue Tai; Stephanie Panier; Abdallah Al-Hakim; Shun-Ichiro Iemura; Yu-Chi Juang; Lara O'Donnell; Ayako Kumakubo; Meagan Munro; Frank Sicheri; Anne-Claude Gingras; Tohru Natsume; Toshio Suda; Daniel Durocher
Journal:  Nature       Date:  2010-08-19       Impact factor: 49.962

Review 2.  Deubiquitinating enzymes as cellular regulators.

Authors:  Jung Hwa Kim; Kyung Chan Park; Sung Soo Chung; Oksun Bang; Chin Ha Chung
Journal:  J Biochem       Date:  2003-07       Impact factor: 3.387

Review 3.  The ubiquitin system.

Authors:  A Hershko; A Ciechanover
Journal:  Annu Rev Biochem       Date:  1998       Impact factor: 23.643

4.  Akt-mTOR Signaling Mediates Abnormalities in the Proliferation and Apoptosis of Ovarian Granulosa Cells in Patients with Polycystic Ovary Syndrome.

Authors:  Wan-Juan Song; Xiaobo Shi; Jing Zhang; Luo Chen; Shu-Xin Fu; Yi-Ling Ding
Journal:  Gynecol Obstet Invest       Date:  2017-07-22       Impact factor: 2.031

5.  The ubiquitination of rag A GTPase by RNF152 negatively regulates mTORC1 activation.

Authors:  Lu Deng; Cong Jiang; Lei Chen; Jiali Jin; Jie Wei; Linlin Zhao; Minghui Chen; Weijuan Pan; Yan Xu; Hongshang Chu; Xinbo Wang; Xin Ge; Dali Li; Lujian Liao; Mingyao Liu; Li Li; Ping Wang
Journal:  Mol Cell       Date:  2015-04-30       Impact factor: 17.970

Review 6.  Cellular strategies for making monoubiquitin signals.

Authors:  Harish N Ramanathan; Yihong Ye
Journal:  Crit Rev Biochem Mol Biol       Date:  2011-10-08       Impact factor: 8.250

7.  Sustained activation of SMAD3/SMAD4 by FOXM1 promotes TGF-β-dependent cancer metastasis.

Authors:  Jianfei Xue; Xia Lin; Wen-Tai Chiu; Yao-Hui Chen; Guanzhen Yu; Mingguang Liu; Xin-Hua Feng; Raymond Sawaya; René H Medema; Mien-Chie Hung; Suyun Huang
Journal:  J Clin Invest       Date:  2014-01-02       Impact factor: 14.808

8.  Two isoforms of otubain 1 regulate T cell anergy via GRAIL.

Authors:  Luis Soares; Christine Seroogy; Heidi Skrenta; Niroshana Anandasabapathy; Patricia Lovelace; Chan D Chung; Edgar Engleman; C Garrison Fathman
Journal:  Nat Immunol       Date:  2003-12-07       Impact factor: 25.606

Review 9.  mTOR signalling: the molecular interface connecting metabolic stress, aging and cardiovascular diseases.

Authors:  Z Yang; X-F Ming
Journal:  Obes Rev       Date:  2012-12       Impact factor: 9.213

10.  OTUB1 de-ubiquitinating enzyme promotes prostate cancer cell invasion in vitro and tumorigenesis in vivo.

Authors:  Diego Iglesias-Gato; Yin-Choy Chuan; Ning Jiang; Charlotte Svensson; Jing Bao; Indranil Paul; Lars Egevad; Benedikt M Kessler; Pernilla Wikström; Yuanjie Niu; Amilcar Flores-Morales
Journal:  Mol Cancer       Date:  2015-01-27       Impact factor: 27.401

View more
  24 in total

Review 1.  Otubain 1: a non-canonical deubiquitinase with an emerging role in cancer.

Authors:  Matthew Saldana; Kacey VanderVorst; Anastasia L Berg; Hyun Lee; Kermit L Carraway
Journal:  Endocr Relat Cancer       Date:  2019-01-01       Impact factor: 5.678

2.  Exosomes derived from human umbilical cord mesenchymal stem cells alleviate inflammatory bowel disease in mice through ubiquitination.

Authors:  Yunbing Wu; Wei Qiu; Xinwei Xu; Jingjing Kang; Jingyan Wang; Yingying Wen; Xudong Tang; Yongmin Yan; Hui Qian; Xu Zhang; Wenrong Xu; Fei Mao
Journal:  Am J Transl Res       Date:  2018-07-15       Impact factor: 4.060

Review 3.  The role of ubiquitination in tumorigenesis and targeted drug discovery.

Authors:  Lu Deng; Tong Meng; Lei Chen; Wenyi Wei; Ping Wang
Journal:  Signal Transduct Target Ther       Date:  2020-02-29

4.  Bipartite binding and partial inhibition links DEPTOR and mTOR in a mutually antagonistic embrace.

Authors:  Maren Heimhalt; Alex Berndt; Jane Wagstaff; Madhanagopal Anandapadamanaban; Olga Perisic; Sarah Maslen; Stephen McLaughlin; Conny Wing-Heng Yu; Glenn R Masson; Andreas Boland; Xiaodan Ni; Keitaro Yamashita; Garib N Murshudov; Mark Skehel; Stefan M Freund; Roger L Williams
Journal:  Elife       Date:  2021-09-14       Impact factor: 8.140

5.  Activation and selectivity of OTUB-1 and OTUB-2 deubiquitinylases.

Authors:  Dakshinamurthy Sivakumar; Vikash Kumar; Michael Naumann; Matthias Stein
Journal:  J Biol Chem       Date:  2020-04-07       Impact factor: 5.157

Review 6.  TGF-β signaling pathway mediated by deubiquitinating enzymes.

Authors:  Soo-Yeon Kim; Kwang-Hyun Baek
Journal:  Cell Mol Life Sci       Date:  2018-10-22       Impact factor: 9.261

7.  Characterization of PMI-5011 on the Regulation of Deubiquitinating Enzyme Activity in Multiple Myeloma Cell Extracts.

Authors:  Manibarathi Vaithiyanathan; Yongmei Yu; Alireza Rahnama; Jacob H Pettigrew; Nora Safa; Dong Liu; Ted J Gauthier; Z Elizabeth Floyd; Adam T Melvin
Journal:  Biochem Eng J       Date:  2020-11-04       Impact factor: 3.978

8.  The deubiquitinase OTUB1 augments NF-κB-dependent immune responses in dendritic cells in infection and inflammation by stabilizing UBC13.

Authors:  Floriana Mulas; Xu Wang; Shanshan Song; Gopala Nishanth; Wenjing Yi; Anna Brunn; Pia-Katharina Larsen; Berend Isermann; Ulrich Kalinke; Antonio Barragan; Michael Naumann; Martina Deckert; Dirk Schlüter
Journal:  Cell Mol Immunol       Date:  2020-02-05       Impact factor: 11.530

9.  Deubiquitinase OTUD5 is a positive regulator of mTORC1 and mTORC2 signaling pathways.

Authors:  Jin Hwa Cho; Kidae Kim; Sung Ah Kim; Sungryul Park; Bi-Oh Park; Jong-Hwan Kim; Seon-Young Kim; Min Jee Kwon; Myeong Hoon Han; Sung Bae Lee; Byoung Chul Park; Sung Goo Park; Jeong-Hoon Kim; Sunhong Kim
Journal:  Cell Death Differ       Date:  2020-10-27       Impact factor: 15.828

Review 10.  Regulation of Cancer Metabolism by Deubiquitinating Enzymes: The Warburg Effect.

Authors:  So-Hee Kim; Kwang-Hyun Baek
Journal:  Int J Mol Sci       Date:  2021-06-08       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.